<DOC>
	<DOCNO>NCT02782754</DOCNO>
	<brief_summary>The purpose study evaluate outcome intracranial germinoma treat chemotherapy plus reduced radiotherapy .</brief_summary>
	<brief_title>Chemotherapy Plus Reduced Radiotherapy Intracranial Germinoma</brief_title>
	<detailed_description>Treatment outcome intracranial germinoma excellent radiotherapy/chemotherapy . However , late sequela unavoidable especially craniospinal irradiation , various effort do reduce dose extent radiotherapy . In study , chemotherapy reduce dose radiotherapy use minimize late sequela patient intracranial germinoma .</detailed_description>
	<mesh_term>Germinoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<criteria>Patients pathologically prove intracranial germinoma Elevated serum/cerebrospinal fluid alphafeto protein Patients organ dysfunction follow ( creatinine elevation , ejection fraction , liver function test &gt; CTCAE grade 2 )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>